These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 30421348)

  • 1. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
    Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
    Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
    Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
    Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
    El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA
    Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
    Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
    Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
    Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
    Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.
    Eraky MA; El-Kholy AA; Rashed GA; Hammam OA; Moharam AF; Abou-Ouf EA; Aly NS; Kishik SM; Abdallah KF; Hamdan DI
    Parasitol Res; 2016 Oct; 115(10):4045-54. PubMed ID: 27325399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
    Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
    Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
    Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
    Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
    Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
    Allam G; Eweas AF; Abuelsaad AS
    Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum.
    Wang X; Yu D; Li C; Zhan T; Zhang T; Ma H; Xu J; Xia C
    Parasit Vectors; 2019 May; 12(1):199. PubMed ID: 31053083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
    El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
    Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.
    Amer EI; Abou-El-Naga IF; Boulos LM; Ramadan HS; Younis SS
    Biomedica; 2022 Mar; 42(1):67-84. PubMed ID: 35471171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
    de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
    Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.